XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Preferred Stock
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ (76,825) $ 149,749 $ 1 $ 6,038   $ (82,864)
Beginning balance, shares at Dec. 31, 2022   61,730,064 3,570,019      
Exercise of common stock options 140     140    
Exercise of common stock options, shares     55,599      
Vesting of restricted stock awards and stock options 73     73    
Conversion of convertible preferred stock to common stock in connection with the Merger 149,749 $ (149,749) $ 18 149,731    
Conversion of convertible preferred stock to common stock in connection with the Merger, shares   (61,730,064) 18,216,847      
Issuance of common stock in the Financing Transaction, net of issuance costs 159,544   $ 13 159,531    
Issuance of common stock in the Financing Transaction, net of issuance costs, shares     12,638,636      
Issuance of common stock to former stockholders of Imara Inc. in connection with the Merger 80,241   $ 7 80,234    
Issuance of common stock to former stockholders of Imara Inc. in connection with the Merger, shares     6,625,176      
Adjustment for change in common stock par value in connection with the Merger     $ 2 (2)    
Reverse recapitalization transaction costs (9,044)     (9,044)    
Stock-based compensation 2,262     2,262    
Net loss (14,724)         (14,724)
Ending balance at Mar. 31, 2023 291,416   $ 41 388,963   (97,588)
Ending balance, shares at Mar. 31, 2023     41,106,277      
Beginning balance at Dec. 31, 2022 (76,825) $ 149,749 $ 1 6,038   (82,864)
Beginning balance, shares at Dec. 31, 2022   61,730,064 3,570,019      
Net loss (31,445)          
Ending balance at Jun. 30, 2023 278,994   $ 41 393,373 $ (111) (114,309)
Ending balance, shares at Jun. 30, 2023     41,151,111      
Beginning balance at Mar. 31, 2023 291,416   $ 41 388,963   (97,588)
Beginning balance, shares at Mar. 31, 2023     41,106,277      
Exercise of common stock options 141     141    
Exercise of common stock options, shares     44,834      
Vesting of restricted stock awards and stock options 74     74    
Stock-based compensation 4,195     4,195    
Net loss (16,721)         (16,721)
Other comprehensive loss (111)       (111)  
Ending balance at Jun. 30, 2023 278,994   $ 41 393,373 (111) (114,309)
Ending balance, shares at Jun. 30, 2023     41,151,111      
Beginning balance at Dec. 31, 2023 245,906   $ 41 400,172 141 (154,448)
Beginning balance, shares at Dec. 31, 2023     41,292,027      
Exercise of common stock options 320     320    
Exercise of common stock options, shares     130,780      
Vesting of restricted stock awards and stock options 73     73    
Vesting of restricted stock units     2,688      
Issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs 89,830   $ 6 89,824    
Issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs, shares     5,357,144      
Stock-based compensation 4,515     4,515    
Net loss (22,738)         (22,738)
Other comprehensive loss (194)       (194)  
Ending balance at Mar. 31, 2024 317,712   $ 47 494,904 (53) (177,186)
Ending balance, shares at Mar. 31, 2024     46,782,639      
Beginning balance at Dec. 31, 2023 245,906   $ 41 400,172 141 (154,448)
Beginning balance, shares at Dec. 31, 2023     41,292,027      
Net loss (42,688)          
Ending balance at Jun. 30, 2024 304,932   $ 47 502,160 (139) (197,136)
Ending balance, shares at Jun. 30, 2024     47,173,466      
Beginning balance at Mar. 31, 2024 317,712   $ 47 494,904 (53) (177,186)
Beginning balance, shares at Mar. 31, 2024     46,782,639      
Exercise of common stock options 1,859     1,859    
Exercise of common stock options, shares     357,277      
Vesting of restricted stock awards and stock options 68     68    
Vesting of restricted stock units     1,749      
Issuance of common stock under the ESPP 320     320    
Issuance of common stock under the ESPP, shares     31,801      
Issuance costs related to the Private Placement (135)     (135)    
Stock-based compensation 5,144     5,144    
Net loss (19,950)         (19,950)
Other comprehensive loss (86)       (86)  
Ending balance at Jun. 30, 2024 $ 304,932   $ 47 $ 502,160 $ (139) $ (197,136)
Ending balance, shares at Jun. 30, 2024     47,173,466